Diltiazem: Difference between revisions

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(One intermediate revision by the same user not shown)
Line 95: Line 95:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Latest revision as of 21:55, 20 March 2026

Administration

  • Type: Calcium channel blocker
  • Dosage Forms
    • IV: 25 mg/5 mL and 50 mg/10 mL bottles
    • Oral: 30 mg, 60 mg, 90 mg
  • Routes of Administration: IV, PO
  • Common Trade Names: Cardizem

Adult Dosing

Atrial fibrillation with rapid ventricular response (if hemodynamically stable)

  • Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes
    • Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions
    • If ineffective after 15 minutes: 0.35mg/kg (max=25mg) over 2 minutes
    • If effective: Start infusion at 5-15 mg/hr
      • Consider 30mg IR PO or home dose to avoid need for a drip

Supraventricular tachycardia (if hemodynamically stable)

  • Same as for atrial fibrillation with rapid ventricular response (see above)

Pediatric Dosing

Special Populations

Pregnancy Rating

  • Pregnancy Rating: C

Lactation risk

  • Lactation: Does appear to diffuse into breast milk, but doses are typically not harmful to infants

Renal Dosing

  • Adult: Not studied, use caution
  • Pediatric: Not studied, use caution

Hepatic Dosing

  • Adult: Not studied, use caution
  • Pediatric: Not studied, use caution

Contraindications

Adverse Reactions

Serious

  • Bradycardia, AV block, BBB
  • Hypotension
  • CHF
  • SJS/TEN

Common

  • Peripheral edema
  • Elevated LFTs
  • Headache
  • Dizziness
  • Nausea/vomiting, diarrhea, contipation
  • Flushing, vasodilation
  • Gingival hyperplagia
  • Myalgia
  • Bronchitis, sinus congestion, dypsnea
  • Hemolytic anemia, thrombocytopenia
  • Extrapyramidal symptoms

Pharmacology

  • Onset of action = 2-3min (IV)
  • Duration of action = 1-3hr (IV)
  • Half life: 3-5h
  • Metabolism: Hepatic
  • Excretion: Urine/feces

Mechanism of Action

  • Class IV - Inhibits Ca influx
    • Slows AV nodal conduction

Comments

Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Atrial fibrillation (main)0.25-0.35 mg/kg IV (typical 20 mg), then 25 mg IV if needed; followed by 60-120 mg PO or dripRate control (1st line CCB)IV/POAdult
Atrial fibrillation with RVR0.25mg/kg (max 20mg) IV over 2min; repeat 0.35mg/kg after 15min; drip 5-20mg/hrFirst-line rate control (CCB)IVAdult
Atrial flutter2.5 mg/min until HR <100 (max 50 mg)Rate controlIVAdult
Nontraumatic thoracic aortic dissection0.25mg/kg load over 2-5min, then 5mg/hr infusionHeart rate control if beta-blocker contraindicatedIVAdult
Paroxysmal supraventricular tachycardia0.25 mg/kg IV over 2 min; may repeat 0.35 mg/kg after 15 min; then infusion 5-20 mg/hrCalcium-channel blocker (2nd line)IV/IV dripAdult

See Also

References